Skip to main content

Table 1 Patient and tumor characteristics

From: Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer

Characteristic N (%)
Age (median years, range) 61 (33–87)
Sex
 Male 35 (61.4)
 Female 22 (38.6)
Performance status (Eastern Cooperative Oncology Group)
 1 26 (45.6)
 2 21 (36.8)
 3 8 (14.0)
 4 2 (3.5)
Histopathology
 Adenocarcinoma 52 (91.2)
 Signet ring cell carcinoma 5 (8.8)
Stage (American Joint Committee on Cancer 8th revision)
 IIA 1 (1.8)
 IIB 2 (3.5)
 IIIA 2 (3.5)
 IIIB 2 (3.5)
 IV 50 (87.7)
Chemotherapy
 Before radiotherapy 43 (75.4)
 During radiotherapy 10 (17.5)
 After radiotherapy 27 (47.4)
Endoscopic hemostasis therapy before radiotherapy
 No 11 (19.3)
 Yes 46 (80.7)
 Baseline hemoglobin (median g/dL, range) 6.6 (3.9–9.9)